(Total Views: 213)
Posted On: 06/23/2020 11:35:47 AM
Post# of 85487

$KDMN News Article - Kadmon Doses First Patient in Phase 1 Clinical Trial of KD033, an Anti-PD-L1/IL-15 Fusion Protein, in Adults with Metastatic or Locally Advanced Solid Tumors https://marketwirenews.com/news-releases/kadm...03912.html


My Twitter: WhyteStocks